Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Regulatory News In Brief

This article was originally published in The Gray Sheet

Executive Summary

Stryker recall: An Oct. 24-initiated recall of 322 Stryker Custom Cranial Implant Kits is Class I, the most serious category, FDA says Dec. 24. The kits were not sterilized according to proper standards, Stryker stated, and therefore may cause serious health problems including infection, intracranial abscess, sepsis, neurological deterioration and even death. Hospitals and company reps have been notified and physicians should stop implanting the product and monitor implanted patients for signs of infection. The kits were distributed from Nov. 5, 2007, through Oct. 23, 2008. On Nov. 20, 2008, FDA sent a 1warning letter to Contract Medical Manufacturing, which makes custom implants for Stryker, for problems with its sterilization process

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT026954

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel